🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bingliang Fang

ORCID: 0000-0001-9225-3010
Computer ScienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.874Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014
Top 31%
0.652DataRank
Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Papers

Driven by 22 papers — median percentile 38. Top paper: “Structure-based classification predicts drug response in EGFR-mutant NSCLC”.

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Nature(2021)10.1038/s41586-021-03898-1
N/A
0.922DataRank · unranked
467 citations

Xiuning Le, R. S. K. Vijayan, J. Kevin Hicks, Simon Heeke, Yasir Y. Elamin +28 more

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Nature Genetics(2021)10.1038/s41588-020-00750-6
N/A
0.790DataRank · unranked
193 citations

Jessica Giordano, Anuj Srivastava, Min Jin Ha, Michael W. Lloyd, Roebi de Bruijn +57 more

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014
Top 31%
0.652DataRank
Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1170
N/A
0.633DataRank · unranked
16 citations

Dong-Wook Kim, Youngchul Kim, Jun Tang, Nicole Kirk, Yongyu Gan +6 more

CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts

Scientific Reports(2022)10.1038/s41598-022-16933-6
N/A
0.464DataRank · unranked
21 citations

Jing Wang, Bingliang Fang, Funda Meric‐Bernstam, Jack A. Roth, Min Jin Ha +1 more

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

Communications Biology(2023)10.1038/s42003-023-04889-w
N/A
0.373DataRank · unranked
11 citations

Mourad Majidi, Bingliang Fang, Feng Meng, Lihui Gao, Ruping Shao +16 more

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

Cancer Research(2024)10.1158/0008-5472.can-23-1349
Top 62%
0.222DataRank
Top 62%3 citations

Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +49 more

Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo

Blood Advances(2021)10.1182/bloodadvances.2021006156
N/A
0DataRank · unranked
8 citations

Ran Zhang, Chenghui Ren, Yi Xu, Shuhong Wu, Carrie Meng +19 more

CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.19.464994
N/A
0DataRank · unranked
3 citations

Jing Wang, Bingliang Fang, Funda Meric‐Bernstam, Jack A. Roth, Min Jin Ha +1 more

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.10.472153
N/A
0DataRank · unranked
1 citations

Mourad Majidi, Bingliang Fang, Feng Meng, Lihui Gao, Ruping Shao +14 more

KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition

iScience(2021)10.1016/j.isci.2021.102649
N/A
0DataRank · unranked
67 citations

Kellen Olszewski, Yilei Zhang, Lavanya Kondiparthi, Xiaoguang Liu, Guang Lei +5 more

mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation

Nature Communications(2021)10.1038/s41467-021-21841-w
N/A
0DataRank · unranked
707 citations

Robert V. Swanda, Litong Nie, Xiaoguang Liu, Chao Wang, Hyemin Lee +12 more

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer

Lung Cancer(2020)10.1016/j.lungcan.2020.08.023
N/A
0DataRank · unranked
20 citations

Lingzhi Hong, Monique B. Nilsson, Shawna M. Hubert, Shuhong Wu, Waree Rinsurongkawong +11 more

Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90

Cells(2022)10.3390/cells11172756
N/A
0DataRank · unranked
16 citations

José G. Treviño, Bingliang Fang, Andrea N. Riner, Vignesh Vudatha, Guohua Zhang +2 more

Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations

Scientific Reports(2022)10.1038/s41598-022-05193-z
N/A
0DataRank · unranked
9 citations

Argun Akçakanat, Scott Kopetz, Coya Tapia, Xiaofeng Zheng, Huiqin Chen +12 more

WNT5A-RHOA axis is a new vulnerability in small-cell lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.14.488408
N/A
0DataRank · unranked
0 citations

Dong Wook Kim, Youngchul Kim, Jun Tang, Nicole Kirk, Yongyu Gan +5 more

CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts

Research Square(2022)10.21203/rs.3.rs-1464274/v1
N/A
0DataRank · unranked
0 citations

Jing Wang, Bingliang Fang, Funda Meric‐Bernstam, Jack A. Roth, Min Jin Ha +1 more

Molecular parameters impacting the success rate of a lung cancer PDX model.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e20592
N/A
0DataRank · unranked
0 citations

Shawna M. Hubert, Ran Zhang, Xingzhi Song, Tatiana V. Karpinets, Annikka Weissferdt +15 more

A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.26.512745
Top 100%
0DataRank
Top 100%0 citations

X. Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +45 more

Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity

Frontiers in Microbiology(2020)10.3389/fmicb.2020.603509
N/A
0DataRank · unranked
43 citations

Peilin Jia, Bingliang Fang, Zhongming Zhao, Teng Liu

Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

(2023)10.1158/0008-5472.c.6514256.v1
N/A
0DataRank · unranked
0 citations

Dong-Wook Kim, Youngchul Kim, Jun Tang, Nicole Kirk, Yongyu Gan +6 more

Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.11.022
N/A
0DataRank · unranked
73 citations

Jacqulyne Robichaux, Matthew H. Herynk, Tina Cascone, Xiuning Le, Yasir Y. Elamin +17 more